Document:

exv10w1

Exhibit 10.1

Alkermes Fiscal Year 2009 Reporting Officer Performance Pay Plan

The Alkermes Fiscal Year 2009 Reporting Officer Performance Pay Plan (the “Plan”) includes the
following elements:

	 	•	 	Our Philosophy
	 
	 	•	 	Eligibility
	 
	 	•	 	Performance Period Company Objectives
	 
	 	•	 	Individual Performance Pay Targets
	 
	 	•	 	Individual Performance
	 
	 	•	 	Size of Company Performance Pay Pool

Our Philosophy

We believe in a pay-for-performance approach that combines individual and Company performance with
compensation to reward employees for the work they do to achieve Company goals. This Plan is
designed to:

	 	•	 	provide upside reward for outstanding Company and individual performance
	 
	 	•	 	motivate the reporting officers to focus on and work together toward achieving Company
and individual goals
	 
	 	•	 	be competitive within our industry

Eligibility

Company reporting officers are eligible to participate in the plan. As of April 1, 2008, the
following reporting officers are eligible to participate in the Plan:

	 	•	 	Chairman of the Board of Directors
	 
	 	•	 	Chief Executive Officer and President
	 
	 	•	 	Senior Vice President, Chief Financial Officer and Treasurer
	 
	 	•	 	Senior Vice President, Corporate Development
	 
	 	•	 	Senior Vice President, General Counsel and Secretary
	 
	 	•	 	Senior Vice President, Research and Development and Chief Medical Officer
	 
	 	•	 	Senior Vice President, Chief Operating Officer

The Performance Period under the Plan consists of the twelve month period from April 1, 2008 to
March 31, 2009. Performance Pay awards will be paid prior to two and one half months after the end
of the Performance Period.

Performance Period Company Objectives

Objective 1

Successfully commercialize VivitrolTM

Objective 2

Build and enhance our proprietary portfolio

 

 

Objective 3

Hit our financial targets

The Compensation Committee of the Board of Directors reserves the right to modify the above
objectives at any time during the course of the Performance Period in response to changing business
goals, needs and operations.

Individual Performance Pay Targets

An individual performance pay range and target as a percentage of base salary will be established
by the Compensation Committee for each of the reporting officers and shall be based generally on
comparable market data. Performance pay awards are to be pro-rated based on the number of days
employed in the Performance Period.

Individual Performance 

Each individual’s performance pay award under the Plan will be determined by the Compensation
Committee of the Board of Directors of the Company. Individual performance against the Company
objectives affects the determination of each individual’s performance pay award relative to that
individual’s target performance pay amount. The CEO of the Company shall provide the Compensation
Committee with recommendations regarding the performance pay for the Senior Vice Presidents. The
percentage of base salary represented by each performance pay award granted under the Plan shall
fall within the target performance pay range.

Size of Performance Pay Plan Pool

The size of the overall performance pay pool under the Plan shall be determined in the absolute
discretion of the Compensation Committee. The size of the overall performance pay pool under the
Plan will equal the aggregate of the individual performance pay awards determined by the
Compensation Committee under the Plan.exv10w1

EXHIBIT 10.1

PURCHASE AGREEMENT

     THIS
PURCHASE AGREEMENT (this “Agreement”) is made as of the 15th day of May 2008, by
and between Flagstar Bancorp, Inc. (the “Company”), a corporation organized under the laws
of the State of Michigan, with its principal offices at 5151 Corporate Drive, Troy, Michigan
48098-2639 and the purchaser whose name and address is set forth on the signature page hereof (the
“Purchaser”).

     IN CONSIDERATION of the mutual covenants contained in this Agreement, the Company and the
Purchaser agree as follows:

     SECTION 1. Authorization of Sale of the Shares. Subject to the terms and conditions
of this Agreement, the Company has authorized the issuance and sale of up to (i) 11,365,000 shares
of the Company’s Common Stock, $0.01 par value (the “Common Stock”) and (ii) 47,982 shares
of the Company’s Mandatory Convertible Non-Cumulative Perpetual Preferred Stock, par value $0.01
and $1,000 liquidation preference per share (the “Preferred Stock,” the Common Stock and
the Preferred Stock together are referred to as the “Shares”), which Preferred Stock shall
convert into shares of Common Stock automatically upon Stockholder Approval (as defined below), as
more fully described in the Certificate of Designations of the
Preferred Stock (the “Certificate
of Designations”), the form of which is attached to this
Agreement as Exhibit A (the “Conversion Shares,” the Shares and the Conversion Shares
together are referred to as the “Securities”).

     SECTION 2. Agreement to Sell and Purchase the Shares. At the Closing (as defined in
Section 3), the Company will, subject to the terms and conditions of this Agreement, issue and sell
to each Purchaser and each Purchaser, severally and not jointly, will buy from the Company, upon
the terms and conditions hereinafter set forth, the respective number of shares of Common Stock at
$4.25 per share (the “Common Stock Purchase Price”) and Preferred Stock at $1,000 per share
(the “Preferred Stock Purchase Price” and, together with the Common Stock Purchase Price,
the “Purchase Price”) as are set forth opposite each Purchaser’s name in Schedule 1 to this
Agreement. At the Closing (as defined below), the Company will enter into this same form of
purchase agreement with certain other investors (the “Other Purchasers”) and complete sales
of Shares to them. The Purchaser and the Other Purchasers are hereinafter sometimes collectively
referred to as the “Purchasers,” and this Agreement and the purchase agreements executed by
the Other Purchasers are hereinafter sometimes collectively referred to as the
“Agreements.” The term “Placement Agent” shall mean Lehman Brothers Inc.

     SECTION 3. Delivery of the Shares at the Closing. The completion of the purchase and
sale of the Shares (the “Closing”) shall occur at the offices of Morrison & Foerster LLP,
1290 Avenue of the Americas, New York, New York 10104 as soon as practicable and as agreed to by
the parties hereto, within three business days following the execution of the Agreements, or on
such later date or at such different location as the parties shall agree in writing, but not prior
to the date that the conditions for Closing set forth below have been satisfied or waived by the
appropriate party (the “Closing Date”).

 

 

     At the Closing, the Purchaser shall deliver, in immediately available funds, the full amount
of the Purchase Price for the Shares being purchased hereunder by wire transfer to an account
designated by the Company and the Company shall deliver to the Purchaser one or more stock
certificates registered in the name of the Purchaser, or in such nominee name(s) as designated by
the Purchaser in writing, representing the number of Shares set forth in Schedule 1 and bearing an
appropriate legend referring to the fact that the Shares were sold in reliance upon the exemption
from registration under the Securities Act of 1933, as amended (the “Securities Act”),
provided by Section 4(2) thereof and Rule 506 thereunder. The Company will promptly substitute one
or more replacement certificates without the legend at such time as the Securities are sold
pursuant to the Registration Statement (as defined herein) or the Securities may be sold pursuant
to Rule 144 under the Securities Act without any restriction as to the number of securities as of a
particular date that can be immediately sold. The name(s) in which the stock certificates are to
be registered are set forth in the Stock Certificate Questionnaire attached hereto as part of
Appendix I.

     The Company’s obligation to complete the purchase and sale of the Shares and deliver such
stock certificate(s) to the Purchaser at the Closing shall be subject to the following conditions,
any one or more of which may be waived by the Company: (a) receipt by the Company of same-day
funds in the full amount of the Purchase Price for the Shares being purchased hereunder; (b)
completion of the purchases and sales under the Agreements with the Other Purchasers; and (c) the
accuracy of the representations and warranties made by the Purchasers (as if such representations
and warranties were made on the Closing Date) and the fulfillment of those undertakings of the
Purchasers to be fulfilled prior to the Closing. The Purchaser’s obligation to accept delivery of
such stock certificate(s) and to pay for the Shares evidenced thereby shall be subject to the
following conditions: (a) the Company shall have filed the Certificate of Designation with the
Secretary of State of the State of Michigan; (b) each of the representations and warranties of the
Company made herein shall be accurate as of the Closing Date; (c) the delivery to the Purchaser by
counsel to the Company of a legal opinion in a form reasonably satisfactory to counsel to the
Placement Agent and the Purchaser; (d) receipt by the Purchaser of a certificate executed by the
chief executive officer and the chief financial or accounting officer of the Company, dated as of
the Closing Date, to the effect that the representations and warranties of the Company set forth
herein are true and correct as of the date of this Agreement and as of such Closing Date and that
the Company has complied with all the agreements and satisfied all the conditions herein on its
part to be performed or satisfied on or prior to such Closing Date; (e) the receipt by the
Purchasers of voting agreements from stockholders holding at least 45% of the outstanding Common
Stock of the Company prior to the date hereof pursuant to which such stockholders will agree to
vote their shares for the Stockholders Approval (as defined below); (f) the Company having received
a gross proceeds of at least $100,000,000 from the sale of the Shares; (g) the approval of the Supplemental
Listing Application by the New York Stock Exchange (the “NYSE”) for the Common Stock and
Conversion Shares; and (h) the fulfillment in all material respects of those undertakings of the
Company to be fulfilled prior to the Closing.

     SECTION 4. Representations, Warranties and Covenants of the Company. The Company
hereby represents and warrants to, and covenants with, the Purchaser as follows:

     4.1 Organization and Qualification.

2

 

          (a) The Company is, and at the Closing Date will be, a corporation duly organized, validly
existing and in good standing under the laws of the State of Michigan. The Company is a savings and
loan holding company under the Home Owners’ Loan Act of 1933, as amended (“HOLA”). The
Company has, and at the Closing Date will have, the power and authority (corporate, governmental,
regulatory and otherwise) and has or will have all necessary approvals, orders, licenses,
certificates, permits and other governmental authorizations (collectively, the
“Authorizations”) to own or lease all of the assets owned or leased by it and to conduct
its business as described in the confidential Private Placement Memorandum dated May 7, 2008
prepared by the Company (including all exhibits, supplements and amendments thereto, the
“Private Placement Memorandum”), except where the failure to have any Authorization would
not have a material adverse effect on the condition (financial or otherwise), assets, business,
properties, prospects or results of operations of the Company and its Subsidiaries (as defined
herein), taken as a whole (a “Material Adverse Effect”). The Company is, and at the Closing
Date will be, duly licensed or qualified to do business and in good standing as a foreign
corporation in all jurisdictions (i) in which the nature of the activities conducted by the Company
requires such qualification and (ii) in which the Company owns or leases real property, except
where the failure to be so licensed or qualified would not have a Material Adverse Effect. The
Amended and Restated Articles of Incorporation of the Company comply in all material respects with
applicable law. A complete and correct copy of the Amended and Restated Articles of Incorporation
of the Company, as amended and as currently in effect, has been delivered or made available to you
or your counsel. The Company’s subsidiaries (each a “Subsidiary” and collectively the
“Subsidiaries”) are listed on Schedule I to this Agreement.

          (b) Flagstar Bank, FSB (the “Bank”) is a Subsidiary of the Company and is a federally
chartered stock savings bank duly organized, validly existing and in good standing under HOLA. The
deposit accounts of the Bank are insured up to applicable limits by the Deposit Insurance Fund
(“DIF”), which is administered by the Federal Deposit Insurance Corporation (the
“FDIC”), and no proceedings for the termination or revocation of such insurance are pending
or, to the knowledge of the Company, threatened. The Bank has the power and authority (corporate,
governmental, regulatory and otherwise) and has or will have all necessary Authorizations to own or
lease all of the assets owned or leased by it and to conduct its business as described in the
Private Placement Memorandum, except where the failure to have any Authorization would not have a
Material Adverse Effect. The Bank is duly licensed or qualified to do business and in good standing
in all jurisdictions (i) in which the nature of the activities conducted by the Bank requires such
qualification and (ii) in which the Bank owns or leases real property, except where the failure to
be so licensed or qualified would not have a Material Adverse Effect. The Federal Stock Savings
Bank Charter (“Bank Charter”) of the Bank complies in all material respects with applicable
law. A complete and correct copy of the Bank Charter, as amended and as currently in effect, has
been delivered or made available to you or your counsel.

          (c) Each of the Subsidiaries is a corporation or other legal entity duly organized, validly
existing and in good standing under the laws of its jurisdiction of organization. Each such
Subsidiary has the power and authority (corporate, governmental, regulatory and otherwise) and has
or will have all necessary Authorizations to own or lease all of the assets owned or leased by it
and to conduct its business as described in the Private Placement Memorandum, except where the
failure to have any Authorization would not have a Material

3

 

Adverse Effect. Each such Subsidiary is duly licensed or qualified to do business and in good
standing as a foreign corporation in all jurisdictions (i) in which the nature of the activities
conducted by such Subsidiary requires such qualification and (ii) in which such Subsidiary owns or
leases real property, except where the failure to be so licensed or qualified would not have a
Material Adverse Effect. The articles or certificate of incorporation or certificate of trust of
each Subsidiary comply in all material respects with applicable law. A complete and correct copy of
the articles or certificate of incorporation or certificate of trust of each Subsidiary, as amended
and as currently in effect, has been delivered or made available to you or your counsel.

     4.2 Reporting Company; Form S-3. The Company is not an “ineligible issuer” (as
defined in Rule 405 promulgated under the Securities Act) and is eligible to register the Common
Stock and Conversion Shares for resale by the Purchaser on a registration statement on Form S-3
(the “Registration Statement”) under the Securities Act. The Company is subject to the
reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and has filed all reports required thereby. Provided none of the Purchasers is deemed
to be an underwriter with respect to any shares, to the Company’s knowledge, there exist no facts
or circumstances (including without limitation any required approvals or waivers or any
circumstances that may delay or prevent the obtaining of accountant’s consents) that reasonably
could be expected to prohibit or delay (other than customary review by the Securities and Exchange
Commission (the “SEC”)) the preparation and filing of the Registration Statement that will
be available for the resale of the Common Stock and Conversion Shares by the Purchaser.

     4.3 Authorized Capital Stock. The Company had duly authorized and validly issued
outstanding capitalization as set forth under the heading “Capitalization” in the Private Placement
Memorandum prepared by the Company as of the date set forth therein; the issued and outstanding
shares of Preferred Stock and Common Stock have been duly authorized and validly issued, are fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws,
were not issued in violation of or subject to any preemptive rights or other rights to subscribe
for or purchase securities, and conform in all material respects to the description thereof
contained in the Private Placement Memorandum. Except for options issued in connection with the
Company’s executive compensation plans as previously disclosed in the Company’s documents filed
with the SEC, the Company does not have outstanding any options to purchase, or any preemptive
rights or other rights to subscribe for or to purchase, any securities or obligations convertible
into, or any contracts or commitments to issue or sell, shares of its capital stock or any such
options, rights, convertible securities or obligations. With respect to each of the Subsidiaries,
(i) all the issued and outstanding shares of such Subsidiary’s capital stock have been duly
authorized and validly issued, are fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, were not issued in violation of or subject to any
preemptive rights or other rights to subscribe for or purchase securities, and (ii) there are no
outstanding options to purchase, or any preemptive rights or other rights to subscribe for or to
purchase, any securities or obligations convertible into, or any contracts or commitments to issue
or sell, shares of such Subsidiary’s capital stock or any such options, rights, convertible
securities or obligations.

     4.4 Issuance, Sale and Delivery of the Shares. The shares of Preferred Stock have
been duly authorized and, when issued, delivered and paid for in the manner set forth in this
Agreement, will be validly issued, fully paid and nonassessable, and will conform in all material

4

 

respects to the description thereof set forth in the Private Placement Memorandum. The shares
of Common Stock have been duly authorized and, when issued, delivered and paid for in the manner
set forth in this Agreement, will be validly issued, fully paid and nonassessable, and will conform
in all material respects to the description thereof set forth in the Private Placement Memorandum.
The Company shall at all times reserve and keep available, out of its authorized but unissued
Common Stock, solely for the purpose of effecting the conversion or redemption of the Shares, the
full number of shares of Common Stock issuable upon the conversion or redemption of all the Shares
from time to time outstanding. The shares of Common Stock that may be issued upon conversion or
redemption of the Shares have been duly authorized, and upon such issuance will be validly issued,
fully paid and nonassessable and no preemptive rights or other rights to subscribe for or purchase
any shares of Common Stock of the Company exist with respect to the issuance of such shares. No
preemptive rights or other rights to subscribe for or purchase any shares of Common Stock or
Preferred Stock of the Company exist with respect to the issuance and sale of the Shares by the
Company pursuant to this Agreement or the Conversion Shares pursuant to the Certificate of
Designations which have not been waived or complied with. No stockholder of the Company has any
right (which has not been waived or has not expired by reason of lapse of time following
notification of the Company’s intention to file the Registration Statement) to require the Company
to register the sale of any capital stock owned by such stockholder under the Registration
Statement. No further approval or authority of the stockholders or the Board of Directors of the
Company will be required for the issuance and sale of the Shares to be sold by the Company as
contemplated herein, except for the Stockholder Approval described in Section 4.5 below.

     4.5 Stockholder Approval. The Company shall provide each stockholder entitled to vote
at a special meeting of stockholders of the Company (the “Stockholder Meeting”), which
shall be promptly called and held not later than 90 days following the Closing Date (the
“Stockholder Meeting Deadline”), a proxy statement, soliciting each such stockholder’s
affirmative vote at the Stockholder Meeting for approval of resolutions providing for the
conversion of the Preferred Stock into Common Stock as described in this Agreement in accordance
with applicable law and the rules and regulations of the NYSE (such affirmative approval being
referred to herein as the “Stockholder Approval”), and the Company shall use its best
efforts to solicit its stockholders’ approval of such resolutions and to cause the Board of
Directors of the Company to recommend to the stockholders that they approve such resolutions. The
Company shall be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting
Deadline; provided, if the Company is unable to obtain the approval of such shareholders within 90
days of the closing date, the Company will undertake to obtain such approval at (i) the next annual
meeting of our shareholders (and each annual meeting thereafter) and (ii) a special meeting of our
shareholders to be held every 180 days following our annual meeting in each year until such
approval is obtained.

     4.6 Due Execution, Delivery and Performance of the Agreements. The Company has full
legal right, corporate power and authority to enter into this Agreement, the Certificate of Rights
and Designations and perform the transactions contemplated hereby. This Agreement has been duly
authorized, executed and delivered by the Company. This Agreement constitutes a legal, valid and
binding agreement of the Company, enforceable against the Company in accordance with its terms,
except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application relating to or

5

 

affecting the enforcement of creditors’ rights and the application of equitable principles
relating to the availability of remedies, subject to 12 U.S.C. §1818(b)(6)(D) (or any successor
statute) and similar bank regulatory powers and to the application of principles of public policy,
and except as rights to indemnity or contribution, including but not limited to, indemnification
provisions set forth in Section 7.4 of this Agreement may be limited by federal or state securities
law or the public policy underlying such laws and general equitable principles relating to the
availability of remedies. The execution and performance of this Agreement by the Company and the
consummation of the transactions herein contemplated will not violate any provision of the Amended
and Restated Articles of Incorporation or Fourth Amended and Restated Bylaws of the Company or the
organizational documents of any Subsidiary and will not result in the creation of any lien, charge,
security interest or encumbrance upon any assets of the Company or any Subsidiary pursuant to the
terms or provisions of, or will not conflict with, result in the breach or violation of, or
constitute, either by itself or upon notice or the passage of time or both, a default under any
agreement, mortgage, deed of trust, lease, franchise, license, indenture, permit or other
instrument to which any of the Company or any Subsidiary is a party or by which any of the Company
or any Subsidiary or their respective properties may be bound or affected and in each case that
would have a Material Adverse Effect or any statute or any authorization, judgment, decree, order,
rule or regulation of any court or any regulatory body, administrative agency or other governmental
agency or body applicable to the Company or any Subsidiary or any of their respective properties.
No consent, approval, authorization or other order of any court, regulatory body, administrative
agency or other governmental agency or body is required for the execution and delivery of this
Agreement or the consummation of the transactions contemplated by this Agreement, except for
compliance with the Blue Sky laws and federal securities laws applicable to the offering of the
Shares. As of the Closing Date, the Certificate of Designations will have been filed with the
Secretary of State of the state of Michigan and will be in full force and effect and enforceable
against the Company in accordance with its terms.

     4.7 Accountants. Virchow, Krause & Company, LLP, who has expressed its opinion with
respect to the consolidated financial statements contained in the Company’s Annual Report on Form
10-K for the year ended December 31, 2007, which is attached as an exhibit to, and made a part of,
the Private Placement Memorandum, are registered independent public accountants, within the meaning
of the Code of Professional Conduct of the American Institute of Certified Public Accountants, as
required by the Securities Act and the rules and regulations promulgated thereunder (the “1933
Act Rules and Regulations”) and by the rules of the Public Accounting Oversight Board.

     4.8 No Defaults or Consents. Neither the execution, delivery and performance of this
Agreement by the Company nor the consummation of any of the transactions contemplated hereby
(including, without limitation, the issuance and sale by the Company of the Securities) will give
rise to a right to terminate or accelerate the due date of any payment due under, or conflict with
or result in the breach of any term or provision of, or constitute a default (or an event which
with notice or lapse of time or both would constitute a default) under, except such defaults that
individually or in the aggregate would not cause a Material Adverse Effect, or require any consent
or waiver under, or result in the execution or imposition of any lien, charge or encumbrance upon
any properties or assets of the Company or any Subsidiary pursuant to the terms of, any indenture,
mortgage, deed of trust or other agreement or instrument to which the Company or any Subsidiary is
a party or by which either the Company or any Subsidiary or any

6

 

of their properties or businesses is bound, or any franchise, license, permit, judgment,
decree, order, statute, rule or regulation applicable to the Company or any of its subsidiaries or
violate any provision of the charter or bylaws of the Company or any of its subsidiaries, except
for such consents or waivers which have already been obtained and are in full force and effect.

     4.9 Contracts. The Material Contracts to which the Company or any Subsidiary is a
party have been previously disclosed in the Company’s documents filed with the SEC or in the
Private Placement Memorandum and have been duly and validly authorized, executed and delivered by
the Company or any Subsidiary and constitute the legal, valid and binding agreements of the Company
or any Subsidiary, enforceable by and against the Company or any Subsidiary, as applicable, in
accordance with their respective terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization or other similar laws relating to enforcement of creditors’
rights generally, and general equitable principles relating to the availability of remedies,
subject to 12 U.S.C. §1818(b)(6)(D) (or any successor statute) and similar bank regulatory powers
and to the application of principles of public policy, and except as rights to indemnity or
contribution may be limited by federal or state securities laws and the public policy underlying
such laws. Material Contract shall mean: (1) any contract or agreement which is a “material
contract” within the meaning of Item 601(b)(10) of Regulation S-K to be performed in whole or in
part after the date of this Agreement; (2) any contract or agreement which limits the freedom of
the Company or any Subsidiary to compete in any line of business; (3) any material contract or
agreement with a labor union or guild (including any collective bargaining agreement); (4) any
contract or agreement which grants any person a right of first refusal, right of first offer or
similar right with respect to any material properties, assets or businesses of the Company or any
Subsidiary; and (5) any contract relating to the acquisition or disposition of any material
business or material assets (whether by merger, sale of stock or assets or otherwise), which
acquisition or disposition is not yet complete or where such contract contains continuing material
obligations, including continuing material indemnity obligations, of the Company or any Subsidiary.

     4.10 No Actions.

          (a) There are no legal or governmental actions, suits or proceedings pending or, to the
Company’s knowledge, threatened against the Company or any Subsidiary before or by any court,
regulatory body or administrative agency or any other governmental agency or body, domestic, or
foreign, which actions, suits or proceedings, individually or in the aggregate, would reasonably be
expected to have a Material Adverse Effect; and no labor disturbance by the employees of the
Company exists or, to the Company’s knowledge, is imminent, that would reasonably be expected to
have a Material Adverse Effect.

          (b) Neither the Company nor any Subsidiary is in violation of any rule or regulation of the
SEC, the Office of Thrift Supervision (the “OTS”) or the FDIC, which would have a Material Adverse
Effect on the condition (financial or otherwise), operations, business, assets or properties of the
Company and the Bank, taken as a whole. Neither the Company nor any Subsidiary is subject to any
directive from the OTS or the FDIC to make any change in the method of conducting its business or
affairs, and the Company and any Subsidiary has conducted its business in compliance with all
applicable statutes and regulations (including, without

7

 

limitation, all regulations, decisions, directives and orders of the OTS and the FDIC), except
where the failure to so comply would not have a Material Adverse Effect.

     4.11 No Restrictions on Subsidiaries. No Subsidiary is currently prohibited, directly
or indirectly, under any order of the OTS (other than orders applicable to savings and loan holding
companies and their subsidiaries generally), or any agreement or other instrument to which it is a
party or is subject, from paying any dividends to the Company, from making any other distribution
on such Subsidiary’s capital stock, from repaying to the Company any loans or advances to such
Subsidiary from the Company or from transferring any of such Subsidiary’s properties or assets to
the Company or any other Subsidiary of the Company, provided, however, that the Bank must seek
prior approval from the OTS at least 30 days before making any capital distribution to the Company.

     4.12 Properties. The Company and each Subsidiary has valid title to all the
properties and assets described as owned by it in the consolidated financial statements included in
the Private Placement Memorandum, free and clear of all liens, mortgages, pledges, or encumbrances
of any kind except (i) those, if any, reflected in such consolidated financial statements, or (ii)
those that would not reasonably be expected to have a Material Adverse Effect. The Company and any
Subsidiary owns or leases all such material properties as are necessary to its operations as now
conducted.

     4.13 No Material Adverse Change.

          (a) There has been no material adverse change in the condition (financial or otherwise),
assets, business, properties, prospects or results of operations of the Company and its
Subsidiaries, taken as a whole, since March 31, 2008. The capitalization, assets, properties and
business of the Company conform in all material respects to the descriptions thereof contained or
incorporated by reference in the Private Placement Memorandum as of the date specified. Subsequent
to the respective dates as of which information is given in the Private Placement Memorandum,
except as otherwise may be indicated therein, neither the Company nor the Bank has issued any
securities or incurred any liability or obligation, direct or contingent, for borrowed money,
except borrowings in the ordinary course of business, or entered into any other transaction not in
the ordinary course of business, which is material in light of the businesses and properties of the
Company and the Bank, taken as a whole. Neither the Company nor any of its Subsidiaries has any
material contingent liabilities of any kind, except as set forth in the Private Placement
Memorandum.

          (b) Except as set forth in the Private Placement Memorandum, no material default (or event
which, with notice or lapse of time, or both, would constitute a material default) exists on the
part of either the Company or the Bank or, to their knowledge, on the part of any other party, in
the due performance and observance of any term, covenant or condition of any agreement to which the
Company or the Bank is a party and which is material to the condition (financial or otherwise) of
the Company and the Bank, taken as a whole. Such agreements are in full force and effect, and no
other party to any such agreement has instituted or, to the knowledge of the Company or the Bank,
threatened any action or proceeding wherein the Company or the Bank is or would be alleged to be in
default thereunder, under circumstances where such action

8

 

or proceeding, if determined adversely to the Company or the Bank, would have a Material
Adverse Effect.

     4.14 Intellectual Property. The Company and its Subsidiaries own or possess all
patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets,
applications and other unpatented or unpatentable proprietary or confidential information, systems
or procedures), trademarks, service marks and trade names (collectively, “Proprietary
Rights”) used in or necessary for the conduct of the business of the Company as now conducted
and as proposed to be conducted as described in the Private Placement Memorandum, except where the
failure to own such Proprietary Rights would not have a Material Adverse Effect. The Company and
its Subsidiaries have the right to use all Proprietary Rights used in or necessary for the conduct
of their respective businesses without infringing the rights of any person or violating the terms
of any licensing or other agreement to which the Company or any Subsidiary is a party and, to the
Company’s knowledge, no person is infringing upon any of the Proprietary Rights, except where the
infringement of or lack of a right to use such Proprietary Rights would not have a Material Adverse
Effect. Except as disclosed in the Private Placement Memorandum, no charges, claims or litigation
have been asserted or, to the Company’s knowledge, threatened against the Company or any Subsidiary
contesting the right of the Company or any Subsidiary to use, or the validity of, any of the
Proprietary Rights or challenging or questioning the validity or effectiveness of any license or
agreement pertaining thereto or asserting the misuse thereof, and, to the Company’s knowledge, no
valid basis exists for the assertion of any such charge, claim or litigation. All licenses and
other agreements to which the Company or any Subsidiary is a party relating to Proprietary Rights
are in full force and effect and constitute valid, binding and enforceable obligations of the
Company or such Subsidiary, subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting creditors’ rights and
to general equity principles, as the case may be, and there have not been and there currently are
not any defaults (or any event which, with notice or lapse of time, or both, would constitute a
default) by the Company or any Subsidiary under any license or other agreement affecting
Proprietary Rights used in or necessary for the conduct of the business of the Company or any
Subsidiary, except for defaults, if any, which would not have a Material Adverse Effect. The
validity, continuation and effectiveness of all licenses and other agreements relating to the
Proprietary Rights and the current terms thereof will not be affected by the transactions
contemplated by this Agreement.

     4.15 Compliance.

          (a) None of the Company nor its Subsidiaries has been advised, nor do any of them have any
reason to believe, that it is not conducting business in compliance with all applicable laws, rules
and regulations of the jurisdictions in which it is conducting business, including, without
limitation, all applicable local, state and federal environmental laws and regulations, except
where failure to be so in compliance would not have a Material Adverse Effect.

          (b) Neither the Company nor the Bank is in violation of its respective Amended and Restated
Articles of Incorporation or Bank Charter, as the case may be, in each case as amended as of the
date hereof, or is in default, in any material respect, in the performance

9

 

of any material obligations, agreement or condition contained in any bond, debenture, note or
any other evidence of indebtedness by which it is bound.

          (c) The Company and its Subsidiaries have, and at the Closing Date will have, complied in all
material respects, except as described or incorporated by reference in the Private Placement
Memorandum, with all laws, regulations, ordinances and orders relating to public health, safety or
the environment (including without limitation all laws, regulations, ordinances and orders relating
to releases, discharges, emissions or disposals to air, water, land or groundwater, to the
withdrawal or use of groundwater, to the use, handling or disposal of polychlorinated biphenyls,
asbestos or urea formaldehyde, to the treatment, storage, disposal or management of hazardous
substances, pollutants or contaminants, or to exposure to toxic, hazardous or other controlled,
prohibited or regulated substances), the violation of which would or might have a Material Adverse
Effect on the consummation of the transactions contemplated by this Agreement. In addition, and
irrespective of such compliance, neither the Company nor any of its Subsidiaries is subject to any
liability for environmental remediation or clean-up, including any liability or class of liability
of the lessee under the Comprehensive Environmental Response, Compensation and Liability Act of
1980, as amended, or the Resource Conservation and Recovery Act of 1976, as amended, which
liability would or might have a Material Adverse Effect on the consummation of the transactions
contemplated by this Agreement.

     4.16 Taxes. Except as publicly disclosed, the Company and each Subsidiary has filed
on a timely basis (giving effect to extensions) all required federal, state and foreign income and
franchise tax returns and has paid or accrued all taxes shown as due thereon, and none of the
Company or any subsidiary has knowledge of a tax deficiency that has been or might be asserted or
threatened against it that could have a Material Adverse Effect. All tax liabilities accrued
through March 31, 2008 have been adequately provided for on the books of the Company.

     4.17 Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other
than income taxes) that are required to be paid in connection with the sale and transfer of the
Shares to be sold to the Purchaser hereunder will have been, fully paid or provided for by the
Company and all laws imposing such taxes will have been fully complied with.

     4.18 Investment Company. The Company is not and, after giving effect to the offering
and sale of the Shares and the application of the proceeds thereof, will not be an “investment
company” or an “affiliated person” of, or “promoter” or “principal underwriter” for an investment
company, as such term is defined in the Investment Company Act of 1940, as amended, and the rules
and regulations of the SEC promulgated thereunder.

     4.19 Offering Materials. Each of the Company, its directors and officers has not
distributed and will not distribute prior to the Closing Date any offering material, including any
“free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in
connection with the offering and sale of the Shares other than the Private Placement Memorandum or
any amendment or supplement thereto and filings made by the Company under the Exchange Act. The
Company has not in the past nor will it hereafter take any action independent of the Placement
Agent to sell, offer for sale or solicit offers to buy any securities of the Company that could
result in the initial sale of the Shares not being exempt from the registration requirements of
Section 5 of the Securities Act.

10

 

     4.20 Insurance. The Company maintains insurance underwritten by insurers of
recognized financial responsibility, of the types and in the amounts that the Company reasonably
believes is adequate for its business, including, but not limited to, insurance covering all real
and personal property owned or leased by the Company against theft, damage, destruction, acts of
vandalism and all other risks customarily insured against, with such deductibles as are customary
for companies in the same or similar business, all of which insurance is in full force and effect.

     4.21 Additional Information. The information contained in the following documents,
which the Placement Agent has furnished to the Purchaser (it being understood that all documents
publicly filed with or publicly furnished to the SEC shall be deemed “furnished” for purposes of
this Section 4.21), or will furnish prior to the Closing, as of the dates thereof, did not contain
an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein in light of the circumstances in which they
were made not misleading:

          (a) the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007;

          (b) the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008;

          (c) the Company’s Definitive Proxy Statement for Annual Meeting of stockholders to be held May
23, 2008;

          (d) the Private Placement Memorandum, including all addenda and exhibits thereto, other than
this Agreement and appendices and exhibits hereto; and

          (e) all
other documents, if any, filed by the Company with the SEC since December 31,
2007, pursuant to the reporting requirements of the Exchange Act.

     The documents incorporated by reference in the Private Placement Memorandum or attached as
exhibits thereto, at the time they became effective or were filed
with the SEC, as the case
may be, complied in all material respects with the requirements of the Exchange Act, as applicable,
and the rules and regulations of the SEC thereunder (the “1934 Act Rules and
Regulations” and, together with the 1933 Act Rule and Regulations, the “Rules and
Regulations”). In the past 12 calendar months, the Company has filed all documents required to
be filed by it prior to the date hereof with the SEC pursuant to the reporting requirements
of the Exchange Act.

     4.22 Price of Common Stock. The Company has not taken, and will not take, directly or
indirectly, any action designed to cause or result in, or that has constituted or that might
reasonably be expected to constitute, the stabilization or manipulation of the price of the Common
Stock to facilitate the sale or resale of the Securities.

     4.23 Use of Proceeds. The Company shall use the proceeds from the sale of the Shares
as described under “Use of Proceeds” in the Private Placement Memorandum.

11

 

     4.24 Non-Public Information. Except as set forth in Section 9, the Company has not
disclosed to the Purchaser, whether in the Private Placement Memorandum or otherwise, information
that would constitute material non-public information as of the Closing Date other than the
existence of the transaction contemplated hereby.

     4.25 Use of Purchaser Name. Except as otherwise required by applicable law or
regulation, the Company shall not use the Purchaser’s name or the name of any of its affiliates in
any advertisement, announcement, press release or other similar public communication unless it has
received the prior written consent of the Purchaser for the specific use contemplated which consent
shall not be unreasonably withheld, conditioned or delayed.

     4.26 Related Party Transactions. No transaction has occurred between or among the
Company, on the one hand, and its affiliates, officers or directors on the other hand, that is
required to have been described under applicable securities laws in its Exchange Act filings and is
not so described in such filings.

     4.27 Off-Balance Sheet Arrangements. There is no transaction, arrangement or other
relationship between the Company and an unconsolidated or other off-balance sheet entity that is
required to be disclosed by the Company in its Exchange Act filings and is not so disclosed or that
otherwise would be reasonably likely to have a Material Adverse Effect. There are no such
transactions, arrangements or other relationships with the Company that may create contingencies or
liabilities that are not otherwise disclosed by the Company in its Exchange Act filings.

     4.28 Governmental Permits, Etc. Neither the Company nor any Subsidiary has received
any notice of proceedings relating to the revocation or modification of any permit that, if the
subject of an unfavorable decision, ruling or finding, could reasonably be expected to have a
Material Adverse Effect.

     4.29 Financial Statements. The consolidated financial statements of the Company and
the related notes and schedules thereto included in its Exchange Act filings fairly present the
financial position, results of operations, stockholders’ equity and cash flows of the Company and
its consolidated Subsidiaries at the dates and for the periods specified therein. Such financial
statements and the related notes and schedules thereto have been prepared in accordance with
generally accepted accounting principles consistently applied throughout the periods involved
(except as otherwise noted therein) and all adjustments necessary for a fair presentation of
results for such periods have been made; provided, however, that the unaudited financial statements
are subject to normal year-end audit adjustments (which are not expected to be material) and do not
contain all footnotes required under generally accepted accounting principles.

     4.30 Listing Compliance. The Company is in compliance with the requirements of the
NYSE for continued listing of the Common Stock thereon. The Company has taken no action designed
to, or, to its knowledge, likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act or the listing of the Common Stock on the NYSE, nor has the Company
received any notification that the SEC or the NYSE is contemplating terminating such
registration or listing. The transactions contemplated by this Agreement will not contravene the
rules and regulations of the NYSE. The Company will comply with all

12

 

requirements of the NYSE with respect to the issuance of the Conversion Shares and shall cause
the Common Stock and Conversion Shares to be listed on the NYSE.

     4.31 Internal Accounting Controls. The Company (i) keeps books, records and accounts
that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the
assets of the Company and the Bank, and (ii) maintains a system of internal accounting controls
sufficient to provide reasonable assurances that (A) transactions are executed in accordance with
management’s general or specific authorization, (B) transactions are recorded as necessary to
permit preparation of financial statements in conformity with generally accepted accounting
principles and to maintain accountability for assets, (C) access to assets is permitted only in
accordance with management’s general or specific authorization and (D) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is
taken with respect to any differences. The Company has disclosure controls and procedures (as
defined in Rules 13a-14 and 15d-14 under the Exchange Act) that are designed to ensure that
material information relating to the Company is made known to the Company’s principal executive
officer and the Company’s principal financial officer or persons performing similar functions. The
Company is otherwise in compliance in all material respects with all applicable provisions of the
Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated thereunder.

     4.32 Foreign Corrupt Practices. Neither the Company, nor any Subsidiary, nor, to the
knowledge of the Company, any director, officer, agent, employee or other Person acting on behalf
of the Company or any Subsidiary has, in the course of its actions for, or on behalf of, the
Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment
to any foreign or domestic government official or employee from corporate funds; (iii) violated or
is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or
(iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment
to any foreign or domestic government official or employee.

     4.33 Employee Relations. Neither the Company nor any Subsidiary is a party to any
collective bargaining agreement. The Company and each Subsidiary believe that their relations with
their employees are good. No executive officer of the Company (as defined in Rule 501(f)
promulgated under the Securities Act) has notified the Company that such officer intends to leave
the Company or otherwise terminate such officer’s employment with the Company. No executive
officer of the Company is, or is now expected to be, in violation of any material term of any
employment contract, confidentiality, disclosure or proprietary information agreement,
non-competition agreement, or any other agreement or any restrictive covenant, and the continued
employment of each such executive officer does not subject the Company or any Subsidiary to any
liability with respect to any of the foregoing matters.

     4.34 ERISA. The Company is in compliance in all material respects with all presently
applicable provisions of the Employee Retirement Income Security Act of 1974, as amended, including
the regulations and published interpretations thereunder (herein called “ERISA”); no
“reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as
defined in ERISA) for which the Company would have any liability; the Company has not incurred and
does not expect to incur liability under (i) Title IV of ERISA with respect to

13

 

termination of, or withdrawal from, any “pension plan”; or (ii) Sections 412 or 4971 of the
Internal Revenue Code of 1986, as amended, including the regulations and published interpretations
thereunder (the “Code”); and each “Pension Plan” for which the Company would have liability
that is intended to be qualified under Section 401(a) of the Code is so qualified in all material
respects and nothing has occurred, whether by action or by failure to act, which would cause the
loss of such qualification.

     4.35 Environmental Matters. There has been no storage, disposal, generation,
manufacture, transportation, handling or treatment of toxic wastes, hazardous wastes or hazardous
substances by the Company or to its knowledge, any Subsidiary (or, to the knowledge of the Company,
any of their predecessors in interest) at, upon or from any of the property now or previously owned
or leased by the Company or any Subsidiary in violation of any applicable law, ordinance, rule,
regulation, order, judgment, decree or permit or that would require remedial action under any
applicable law, ordinance, rule, regulation, order, judgment, decree or permit; there has been no
material spill, discharge, leak, emission, injection, escape, dumping or release of any kind into
such property or into the environment surrounding such property of any toxic wastes, medical
wastes, solid wastes, hazardous wastes or hazardous substances due to or caused by the Company or
any Subsidiary or with respect to which the Company or any Subsidiary have knowledge; the terms
“hazardous wastes”, “toxic wastes”, “hazardous substances”, and “medical wastes” shall have the
meanings specified in any applicable local, state, federal and foreign laws or regulations with
respect to environmental protection.

     4.36 Integration; Other Issuances of Shares. Neither the Company nor any Subsidiary
or any affiliates, nor any Person acting on its or their behalf, has issued any shares of Preferred
Stock or Common Stock or shares of any other series of preferred stock, or other securities or
instruments convertible into, exchangeable for or otherwise entitling the holder thereof to acquire
shares of Common Stock or Preferred Stock which would be integrated with the sale of the Shares to
such Purchaser for purposes of the Securities Act or of any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations of any exchange or
automated quotation system on which any of the securities of the Company are listed or designated,
nor will the Company or its subsidiaries or affiliates take any action or steps that would require
registration of any of the Shares under the Securities Act or cause the offering of the Shares to
be integrated with other offerings. Assuming the accuracy of the representations and warranties of
Purchasers, the initial offer and sale of the Shares by the Company to the Purchasers pursuant to
this Agreement will be exempt from the registration requirements of the Securities Act.

     4.37 Filing of Form 8-K. Prior to 8:30 a.m. New York City time on the first business
day after the date hereof, the Company shall issue a press release announcing the execution of this
Agreement and the Company shall file a Current Report on Form 8-K (the “8-K Filing”)
describing the material terms of the transactions contemplated by the Agreements (for clarification
purposes only and without implication to the contrary, the transactions contemplated by this
Agreement include only the transaction between the Company and the Purchaser and do not include any
other transaction between the Company and any other third party purchaser of the Company’s
securities), and attaching as an exhibit to such Form 8-K a form of this Agreement. Except as set
forth in Section 9, following the 8-K Filing, the Purchasers shall no longer be in possession of
material non-public information. The Company shall not, and shall

14

 

cause each of its Subsidiaries and its and each of their respective officers, directors,
employees and agents, not to, provide any Purchaser with any material, nonpublic information
regarding the Company or any of its Subsidiaries from and after the filing of the 8-K Filing with
the SEC without the express written consent of such Purchaser.

     4.38 Risk Management Instruments. All material derivative instruments, including,
swaps, caps, floors and option agreements, whether entered into for the Company’s own account, or
for the account of one or more of the Subsidiaries or their customers, were entered into (1) only
in the ordinary course of business, (2) in accordance with prudent practices and in all material
respects with all applicable laws, rules, regulations and regulatory policies and (3) with
counterparties believed to be financially responsible at the time; and each of them constitutes the
valid and legally binding obligation of the Company or one of the Subsidiaries, enforceable in
accordance with its terms. Neither the Company nor the Subsidiaries, nor, to the knowledge of the
Company, any other party thereto, is in breach of any of its material obligations under any such
agreement or arrangement.

     4.39 Mortgage Banking Business. Except as has not had and would not reasonably be
expected to have a Material Adverse Effect:

     (1) The Company and each Subsidiary has complied with, and all documentation in
connection with the origination, processing, underwriting and credit approval of any
mortgage loan originated, purchased or serviced by the Company or any Subsidiary satisfied,
(A) all applicable federal, state and local laws, rules and regulations with respect to the
origination, insuring, purchase, sale, pooling, servicing, subservicing, or filing of claims
in connection with mortgage loans, including all laws relating to real estate settlement
procedures, consumer credit protection, truth in lending laws, usury limitations, fair
housing, transfers of servicing, collection practices, equal credit opportunity and
adjustable rate mortgages, (B) the responsibilities and obligations relating to mortgage
loans set forth in any agreement between the Company or any Subsidiary and any Agency, Loan
Investor or Insurer, (C) the applicable rules, regulations, guidelines, handbooks and other
requirements of any Agency, Loan Investor or Insurer and (D) the terms and provisions of any
mortgage or other collateral documents and other loan documents with respect to each
mortgage loan; and

     (2) No Agency, Loan investor or Insurer has (A) claimed in writing that the Company or
any Subsidiary has violated or has not complied with the applicable underwriting standards
with respect to mortgage loans sold by the Company or any Subsidiary to a Loan Investor or
Agency, or with respect to any sale of mortgage servicing rights to a Loan Investor, (B)
imposed in writing restrictions on the activities (including commitment authority) of the
Company or any Subsidiary or (B) indicated in writing to the Company or any Subsidiary that
it has terminated or intends to terminate its relationship with the Company or any
Subsidiary for poor performance, poor loan quality or concern with respect to the Company’s
or any Subsidiary’s compliance with laws.

     (3) For purposes of this Section 4.39:

15

 

     (A) “Agency” shall mean the Federal Housing Administration, the Federal Home
Loan Mortgage Corporation, the Farmers Home Administration (now known as Rural
Housing and Community Development Services), the Federal National Mortgage
Association, the Federal National Mortgage Association, the United States Department
of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of
Agriculture or any other federal or state agency with authority to (i) authority to
determine any investment, origination, lending or servicing requirements with regard
to mortgage loans originated, purchased or serviced by the Company or any Subsidiary
or (ii) originate, purchase, or service mortgage loans, or otherwise promote
mortgage lending, including without limitation state and local housing finance
authorities.

     (B) “Loan Investor” shall mean any person (including an Agency) having a
beneficial interest in any mortgage loan originated, purchased or serviced by the
Company or any Subsidiary or a security backed by or representing an interest in any
such mortgage loan; and

     (C) “Insurer” means a person who insures or guarantees for the benefit of the
mortgagee all or any portion of the risk of loss upon borrower default on any of the
mortgage loans originated, purchased or serviced by the Company or any Subsidiary,
including, the Federal Housing Administration, the United States Department of
Veterans’ Affairs, the Rural Housing Service of the U.S. Department of Agriculture
and any private mortgage insurer, and providers of hazard, title or other insurance
with respect to such mortgage loans or the related collateral.

     4.40 U.S. Real Property Holding Corporation Status. The Company is not, nor has ever
been, a U.S. real property holding corporation within the meaning of Section 897 of the Internal
Revenue Code of 1986, as amended.

     4.41 Shell Company Status. The Company is not, nor has ever been, an issuer of the
type described in Rule 144(i)(l) under the Securities Act.

     4.42 Solvency. The Company and each of its Subsidiaries does and will after giving
effect to the to the transactions contemplated hereby to occur at the Closing and the sale of
securities to the Other Purchasers (a) own assets the fair saleable value of which are (i) greater
than the total amount of its liabilities (including known contingent liabilities) and (ii) greater
than the amount that will be required to pay the probable liabilities of its existing debts as they
become absolute and matured considering the financing alternatives reasonably available to it and
(b) not have capital that will be unreasonably small in relation to its business as presently
conducted or any contemplated. The Company has no knowledge of any facts or circumstances which
lead it to believe that it or any of its Subsidiaries will be required to file for reorganization
or liquidation under the bankruptcy or reorganization laws of any jurisdiction, and has no present
intent to so file.

     SECTION 5. Representations, Warranties and Covenants of the Purchaser. The Purchaser
represents and warrants to, and covenants with, the Company that:

16

 

     5.1 Experience. (i) The Purchaser is knowledgeable, sophisticated and experienced in
financial and business matters, in making, and is qualified to make, decisions with respect to
investments in shares representing an investment decision like that involved in the purchase of the
Securities, including investments in securities issued by the Company and comparable entities, has
the ability to bear the economic risks of an investment in the Securities and has reviewed
carefully the Private Placement Memorandum and has requested, received, reviewed and considered all
information it deems relevant in making an informed decision to purchase the Securities; (ii) the
Purchaser is acquiring the number of Shares set forth in Section 2 above in the ordinary course of
its business and for its own account for investment only and with no present intention of
distributing any of the Securities or any arrangement or understanding with any other persons
regarding the distribution of such Securities (this representation and warranty not limiting the
Purchaser’s right to sell pursuant to the Registration Statement or in compliance with the
Securities Act and the Rules and Regulations, or, other than with respect to any claims arising out
of a breach of this representation and warranty, the Purchaser’s right to indemnification under
Section 7.4); (iii) the Purchaser will not, directly or indirectly, offer, sell, pledge, transfer
or otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a
pledge of) any of the Securities, nor will the Purchaser engage in any short sale that results in a
disposition of any of the Securities by the Purchaser, except in compliance with the Securities Act
and the Rules and Regulations and any applicable state securities laws; (iv) the Purchaser has
completed or caused to be completed the Registration Statement Questionnaire attached hereto as
part of Appendix I, for use in preparation of the Registration Statement, and the answers
thereto are true and correct as of the date hereof and will be true and correct as of the effective
date of the Registration Statement and the Purchaser will notify the Company immediately of any
material change in any such information provided in the Registration Statement Questionnaire until
such time as the Purchaser has sold all of its Securities or until the Company is no longer
required to keep the Registration Statement effective; (v) the Purchaser has, in connection with
its decision to purchase the number of Shares set forth in Section 2 above, relied solely upon the
Private Placement Memorandum and the representations and warranties of the Company contained
herein; (vi) the Purchaser has had an opportunity to discuss this investment with representatives
of the Company and ask questions of them and (vii) the Purchaser is an “accredited investor” within
the meaning of Rule 501(a) of Regulation D promulgated under the Securities Act.

     5.2 Reliance on Exemptions. The Purchaser understands that the Shares are being
offered and sold to it in reliance upon specific exemptions from the registration requirements of
the Securities Act, the Rules and Regulations and state securities laws and that the Company is
relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations,
warranties, agreements, acknowledgments and understandings of the Purchaser set forth herein in
order to determine the availability of such exemptions and the eligibility of the Purchaser to
acquire the Shares.

     5.3 Confidentiality. For the benefit of the Company, the Purchaser previously agreed
with the Placement Agent to keep confidential all information concerning this private placement.
The Purchaser understands that the information contained in the Private Placement Memorandum is
strictly confidential and proprietary to the Company and has been prepared from the Company’s
publicly available documents and other information and is being submitted to the Purchaser solely
for such Purchaser’s confidential use. The Purchaser agrees to use the

17

 

information contained in the Private Placement Memorandum for the sole purpose of evaluating a
possible investment in the Securities and the Purchaser acknowledges that it is prohibited from
reproducing or distributing the Private Placement Memorandum, this Agreement, or any other offering
materials or other information provided by the Company in connection with the Purchaser’s
consideration of its investment in the Company, in whole or in part, or divulging or discussing any
of their contents, except to its financial, investment or legal advisors in connection with its
proposed investment in the Securities. Further, the Purchaser understands that the existence and
nature of all conversations and presentations, if any, regarding the Company and this offering must
be kept strictly confidential. The Purchaser understands that the federal securities laws impose
restrictions on trading based on information regarding this offering. In addition, the Purchaser
hereby acknowledges that unauthorized disclosure of information regarding this offering may result
in a violation of Regulation FD. The obligations set forth in
this Section 5.3 will terminate upon the filing by the Company of
the press release and the filing of a Form 8-K with the SEC. The foregoing
agreements shall not apply to any information that is or becomes publicly available through no
fault of the Purchaser, or that the Purchaser is legally required to disclose; provided, however,
that if the Purchaser is requested or ordered to disclose any such information pursuant to any
court or other government order or any other applicable legal procedure, it shall provide the
Company with prompt notice of any such request or order in time sufficient to enable the Company to
seek an appropriate protective order.

     Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement should
be considered to impose on the Purchaser any limitation on disclosure of the tax treatment or tax
structure of the transactions or matters described herein.

     5.4 Investment Decision. The Purchaser understands that nothing in the Agreement or
any other materials presented to the Purchaser in connection with the purchase and sale of the
Shares, including the Private Placement Memorandum, constitutes legal, tax or investment advice.
The Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion,
has deemed necessary or appropriate in connection with its purchase of the Shares.

     5.5 Risk of Loss. The Purchaser understands that its investment in the Securities
involves a significant degree of risk, including a risk of total loss of the Purchaser’s
investment, and the Purchaser has full cognizance of and understands all of the risk factors
related to the Purchaser’s purchase of the Securities, including, but not limited to, those set
forth as “Risk Factors” in the Private Placement Memorandum. The Purchaser understands that the
market price of the Common Stock has been volatile, that there is no existing market for the
Preferred Stock and that no representation is being made as to the future value of the Securities.

     5.6 Legend. The Purchaser understands that, until such time as the Registration
Statement has been declared effective or the Securities may be sold pursuant to Rule 144 under the
Securities Act without any restriction as to the number of securities as of a particular date that
can then be immediately sold, the Securities will bear a restrictive legend in substantially the
following form:

“THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF

18

 

1933, AS AMENDED (THE “SECURITIES ACT”) OR THE SECURITIES
LAWS OF ANY STATE OR OTHER JURISDICTION. THE SHARES MAY NOT BE
OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT
TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2)
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES
LAWS AND THE SECURITIES LAWS OF OTHER JURISDICTIONS, AND IN THE CASE
OF A TRANSACTION EXEMPT FROM REGISTRATION, UNLESS THE COMPANY HAS
RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT
SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES
ACT AND SUCH OTHER APPLICABLE LAWS.”

     5.7 Transfer Restrictions. Consistent with the legend set forth in Section 5.6, the
Securities may only be disposed of in compliance with state and federal securities laws. In
connection with any transfer of Securities other than pursuant to the Registration Statement, the
Company may require the transferor to provide to the Company an opinion of counsel selected by the
transferor and reasonably acceptable to the Company, the form and substance of which opinion shall
be reasonably satisfactory to the Company, to the effect that such transfer does not require
registration of the transferred Securities under the Securities Act. As a condition of such
transfer (unless effected pursuant to the Registration Statement or under Rule 144), any such
transferee shall agree in writing to be bound by the terms of this Agreement and shall have the
rights of a Purchaser under this Agreement. The certificates representing the Shares and the
Conversion Shares may be subject to a stop transfer order for the purpose of enforcing the
foregoing provisions, and the Company will instruct the transfer agent to transfer Securities to a
transferee if the foregoing provisions are complied with and if, in the case of a transfer pursuant
to the Registration Statement, the transferor causes the Prospectus (as defined in Section 5.9) to
be delivered to the transferee. At such time as the Securities are no longer required to bear a
restrictive legend, the Company agrees that it will, no later than three business days after
delivery by the Purchaser to the Company or its transfer agent of a certificate (in the case of a
transfer, in the proper form for transfer) representing Securities issued with the foregoing
restrictive legend, deliver or cause to be delivered to the Purchaser a certificate representing
such Securities that is free from all restrictive and other legends. The Company shall not make
any notation on its records or give instructions to its transfer agent that enlarge the
restrictions on transfer set forth in this Section.

     5.8 Residency. The Purchaser’s principal executive offices are in the jurisdiction
set forth immediately below the Purchaser’s name on the signature pages hereto.

     5.9 Public Sale or Distribution. The Purchaser hereby covenants with the Company not
to make any sale of the Securities under the Registration Statement without complying with the
provisions of this Agreement and without effectively causing the prospectus delivery requirement
under the Securities Act to be satisfied (whether physically or through compliance

19

 

with Rule 172 under the Securities Act or any similar rule), and the Purchaser acknowledges
and agrees that such Securities are not transferable on the books of the Company unless the
certificate submitted to the transfer agent evidencing the Securities is accompanied by a separate
Purchaser’s Certificate of Subsequent Sale: (i) in the form of Appendix II hereto, (ii)
executed by an officer of, or other authorized person designated by, the Purchaser, and (iii) to
the effect that (A) the Securities have been sold in accordance with the Registration Statement,
the Securities Act and any applicable state securities or Blue Sky laws and (B) the prospectus
delivery requirement effectively has been satisfied. The Purchaser acknowledges that there may
occasionally be times when the Company must suspend the use of the prospectus (the
“Prospectus”) forming a part of the Registration Statement (a “Suspension”) until
such time as an amendment to the Registration Statement has been filed by the Company and declared
effective by the Commission, or until such time as the Company has filed an appropriate report with
the Commission pursuant to the Exchange Act. Without the Company’s prior written consent, which
consent shall not unreasonably be withheld or delayed, the Purchaser shall not use any written
materials to offer the Securities for resale other than the Prospectus, including any “free writing
prospectus” as defined in Rule 405 under the Securities Act. The Purchaser covenants that it will
not sell any Securities pursuant to said Prospectus during the period commencing at the time when
Company gives the Purchaser written notice of the suspension of the use of said Prospectus and
ending at the time when the Company gives the Purchaser written notice that the Purchaser may
thereafter effect sales pursuant to said Prospectus. Notwithstanding the foregoing, the Company
agrees that no Suspension shall be for a period of longer than 45 consecutive days, and no
Suspension shall be for a period longer than 60 days in the aggregate in any 365 day period and may
not be used by the Company more than three times during any 365 day period. The Purchaser further
covenants to notify the Company promptly of the sale of all of its Securities.

     5.10 Organization; Validity; Enforcements. The Purchaser further represents and
warrants to, and covenants with, the Company that (i) the Purchaser has full right, power,
authority and capacity to enter into this Agreement and to consummate the transactions contemplated
hereby and has taken all necessary action to authorize the execution, delivery and performance of
this Agreement, (ii) the making and performance of this Agreement by the Purchaser and the
consummation of the transactions herein contemplated will not violate any provision of the
organizational documents of the Purchaser or conflict with, result in the breach or violation of,
or constitute, either by itself or upon notice or the passage of time or both, a default under any
material agreement, mortgage, deed of trust, lease, franchise, license, indenture, permit or other
instrument to which the Purchaser is a party or, any statute or any authorization, judgment,
decree, order, rule or regulation of any court or any regulatory body, administrative agency or
other governmental agency or body applicable to the Purchaser, (iii) no consent, approval,
authorization or other order of any court, regulatory body, administrative agency or other
governmental agency or body is required on the part of the Purchaser for the execution and delivery
of this Agreement or the consummation of the transactions contemplated by this Agreement, (iv) upon
the execution and delivery of this Agreement, this Agreement shall constitute a legal, valid and
binding obligation of the Purchaser, enforceable in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other laws of general application relating to or the enforcement of creditor’s rights and the
application of equitable principles relating to the availability of remedies, and except as rights
to indemnity or contribution, including, but not limited to, the

20

 

indemnification provisions set forth in Section 7.4 of this Agreement, may be limited by
federal or state securities laws or the public policy underlying such laws and (v) there is not in
effect any order enjoining or restraining the Purchaser from entering into or engaging in any of
the transactions contemplated by this Agreement.

     5.11 Short Sales. After
the date the Purchaser entered into a confidentiality undertaking
with the Placement Agent with respect to the transactions
contemplated hereby,
the Purchaser has not taken, and prior to the public announcement of the transaction, the Purchaser
shall not take, any action that has caused or will cause the Purchaser to have, directly or
indirectly, sold or agreed to sell any shares of Common Stock, effected any short sale of Common
Stock, whether or not against the box, established any “put equivalent position” (as defined in
Rule 16a-1(h) under the Exchange Act) with respect to the Common Stock, granted any other right
(including, without limitation, any put or call option) with respect to the Common Stock or with
respect to any security that includes, relates to or derived any significant part of its value from
the Common Stock.

     SECTION 6. Survival of Agreements; Non-Survival of Company Representations and
Warranties. Notwithstanding any investigation made by any party to this Agreement or by the
Placement Agent, all covenants and agreements made by the Company and the Purchaser herein and in
the certificates for the Shares delivered pursuant hereto shall survive the execution of this
Agreement, the delivery to the Purchaser of the Shares being purchased and the payment therefor.
All representations and warranties, made by the Company and the Purchaser herein and in the
certificates for the Shares delivered pursuant hereto shall survive for a period of two years
following the later of the execution of this Agreement, the delivery to the Purchaser of the Shares
being purchased and the payment therefor.

     SECTION 7. Registration of the Common Stock and Conversion Shares; Compliance with the
Securities Act. 

     7.1 Registration Procedures and Expenses. The Company shall:

          (a) as soon as practicable, but in no event later than thirty days following the Closing Date
(the “Filing Deadline”), prepare and file with the
SEC the Registration Statement
relating to the resale of the Common Stock and or Conversion Shares (including shares of Common
Stock issuable as a result of an anti-dilution adjustment to the Conversion Price (as defined in
the Articles of Amendment) and any capital stock of the Company issued with respect to the Shares
or the Conversion Shares as a result of any stock split, stock dividend, recapitalization, exchange
or similar event or otherwise (collectively, the “Registrable Securities”) by the Purchaser
and the Other Purchasers from time to time on the NYSE, or the facilities of any national
securities exchange on which the Common Stock is then traded or in privately-negotiated
transactions;

          (b) use
its best efforts, subject to receipt of necessary information from the Purchasers, to
cause the SEC to declare the Registration Statement effective within 45 days or, if the
Registration Statement is selected for review by the SEC, 120 days after the Closing Date,
and in any event no later than five business days following
notification from the SEC that
the Registration Statement will not be subject to review or that the
SEC has no further
comments to the Registration Statement (the “Effective Deadline”);

21

 

          (c) promptly
prepare and file with the SEC such amendments and supplements to the
Registration Statement and the Prospectus used in connection therewith as may be necessary to keep
the Registration Statement effective until the earliest of (i) one year after the effective date of
the Registration Statement or (ii) such time as Registrable Securities become eligible for resale
by each of the Purchasers without any volume limitations or other restrictions pursuant to Rule 144
under the Securities Act or any other rule of similar effect; provided that, for the avoidance of
doubt, in no event shall the Company have any obligation to keep the Registration Statement
effective after such time as all of the Registrable Securities have been sold pursuant to the
Registration Statement or Rule 144;

          (d) furnish to the Purchaser with respect to the Registrable Securities registered under the
Registration Statement (and to each underwriter, if any, of such Registrable Securities) such
number of copies of prospectuses and such other documents as the Purchaser may reasonably request,
in order to facilitate the public sale or other disposition of all or any of the Registrable
Securities by the Purchaser;

          (e) file documents required of the Company for normal Blue Sky clearance in states specified
in writing by the Purchaser; provided, however, that the Company shall not be
required to qualify to do business or consent to service of process in any jurisdiction in which it
is not now so qualified or has not so consented;

          (f) bear all expenses in connection with the procedures in paragraphs (a) through (e) of this
Section 7.1 and the registration of the Registrable Securities pursuant to the Registration
Statement, other than fees and expenses, if any, of counsel or other advisers to the Purchaser or
the Other Purchasers or underwriting discounts, brokerage fees and commissions incurred by the
Purchaser or the Other Purchasers, if any in connection with the offering of the Registrable
Securities pursuant to the Registration Statement;

          (g) file a Form D with respect to the Shares as required under Regulation D and to provide a
copy thereof to the Purchaser promptly after filing;

          (h) issue a press release describing the transactions contemplated by this Agreement on the
Closing Date;

          (i) in order to enable the Purchasers to sell the Registrable Securities under Rule 144 to the
Securities Act, for a period of one year from Closing, use its reasonable best efforts to comply
with the requirements of Rule 144, including without limitation, use its reasonable best efforts to
comply with the requirements of Rule 144(c)(1) with respect to public information about the Company
and to timely file all reports required to be filed by the Company under the Exchange Act.

          (j) ensure that the Registration Statement (including any amendments or supplements thereto
and prospectuses contained therein) shall not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein, or necessary to make the statements
therein (in the case of prospectuses, in the light of the circumstances in which they were made)
not misleading;

22

 

          (k) notify the Purchaser in writing of the happening of any event, as promptly as practicable
after becoming aware of such event, as a result of which the prospectus included in a Registration
Statement, as then in effect, includes an untrue statement of a material fact or omission to state
a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading (provided that the Company
shall endeavor that such notice not contain any material, nonpublic information), and, promptly
prepare a supplement or amendment to such Registration Statement to correct such untrue statement
or omission;

          (l) use its reasonable best efforts to prevent the issuance of any stop order or other
suspension of effectiveness of a Registration Statement, or the suspension of the qualification of
any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension
is issued, to obtain the prompt withdrawal of such order or suspension and to notify each Purchaser
who holds Registrable Securities being sold of the issuance of such order and the resolution
thereof or its receipt of actual written notice of the initiation or written threat of any
proceeding for such purpose; and

          (m) include in the “plan of distribution” section of the Registration Statement disclosure
substantially to the effect that: “The selling stockholders may enter into derivative transactions
with third parties, or sell securities not covered by this prospectus to third parties in privately
negotiated transactions.

          (n) refrain
from preparing and filing with the SEC other Registration Statements until
the Registration Statement relating to the Registrable Securities is effective.

          The Company understands that the Purchaser disclaims being an underwriter, but the Purchaser
being deemed an underwriter shall not relieve the Company of any obligations it has hereunder. If
the SEC requires that the Purchaser be named as an underwriter in the Registration Statement, the
Purchaser may (and the Company will use its best efforts to allow) withdraw its Securities from the
Registration Statement. A draft of the proposed form of the Registration Statement Questionnaire
related to the Registration Statement to be completed by the Purchaser is attached hereto as
Appendix I.

     7.2 Additional Registration Statements. If for any reason, the SEC does not permit
all Registrable Securities to be included in such Registration Statement (such that the Registration
Statement may be used for resales in a manner that does not constitute, in the SEC’s view, an
offering by the Company and that permits the continuous resale at the market by the Purchasers
participating therein without being named therein as
“underwriters”), then;

          (a) The Company shall (i) first, exclude the shares held by any officer or
director of the Company or any Affiliate of any such officer or director and (ii) second, reduce
the number of Registrable Securities to be included in such Registration Statement by the Purchaser
and all Other Purchasers until such time as the SEC shall so permit such Registration Statement to
become effective and be used for resales in a manner that does not constitute an offering by the
Company and that permits the continuous resale at the market by the Purchasers participating
therein without being named therein as “underwriters.” In making such reduction, the Company shall
reduce the number of shares to be included by all such Purchasers on a pro rata basis (based upon
the number of Registrable Securities otherwise required to be included for each such Purchaser).
In no event shall a Purchaser be required to be named as an “underwriter” in a Registration
Statement without such Purchaser’s prior written consent; and

          (b) The Company shall prepare and file with the SEC one or more separate
Registration Statements that meet the criteria set forth in the first sentence of this
Section 7.2 with respect to any such Registrable Securities not included in the
previous Registration Statement. The Company will then use its best efforts at the first
opportunity that is permitted by the SEC, but in no event later than the later of (60) days from
the date substantially all of the Registrable Securities registered under the Registration
Statement have been sold by the Purchasers or six (6) months from the date the initial
Registration Statement referred to in Section 7.1 was declared effective, to register
for resale the Registrable Securities that have been excluded from being registered (provided such
Registration Statement meets the criteria set forth in the first sentence of this Section 7.2).
The Company shall use its best efforts to cause any such Registration Statement to be
declared effective within 90 days following the filing thereof or, in the event of a review of the
registration statement by the SEC, within 120 days following the filing thereof, (and in any
event no later than five business days following notification from the SEC that the Registration
Statement will not be subject to review or that the SEC has no further comments to the Registration
Statement) and to remain continuously effective for the Registration Period. In the event
the SEC raises objections to any such subsequent Registration Statement, the procedures set forth
in this Section 7.2 shall again be followed.

23

 

     7.3 Transfer of Securities After Registration. The Purchaser agrees that it will not
effect any disposition of the Securities or its right to purchase the Securities that would
constitute a sale within the meaning of the Securities Act or pursuant to any applicable state
securities laws, except as contemplated by a Registration Statement referred to in Section 7.1 or
Section 7.2 as otherwise permitted by law, and that it will promptly notify the Company of any changes in the
information set forth in the Registration Statement regarding the Purchaser or its plan of
distribution.

     7.4 Indemnification. For the purpose of this Section 7.4:

(i) the term “Purchaser/Affiliate” shall mean any
affiliate of the Purchaser, including a transferee who is an
affiliate of the Purchaser, and any person who controls the
Purchaser or any affiliate of the Purchaser within the meaning
of Section 15 of the Securities Act or Section 20 of the
Exchange Act; and

(ii) the term “
Registration Statement” shall include
any preliminary prospectus, final prospectus, free writing
prospectus, exhibit, supplement or amendment included in or
relating to, and any document incorporated by reference in, the
Registration Statement referred to in Section 7.1 or
Section 7.2.

          (a) The Company agrees to indemnify and hold harmless the Purchaser and each
Purchaser/Affiliate, against any losses, claims, damages, liabilities or expenses, joint or
several, to which the Purchaser or Purchaser/Affiliates may become subject, under the Securities
Act, the Exchange Act, or any other federal or state statutory law or regulation, or at common law
or otherwise (including in settlement of any litigation, if such settlement is effected with the
consent of the Company, which consent shall not be unreasonably withheld), insofar as such losses, claims, damages, liabilities or expenses
(or actions in respect thereof as contemplated below) arise out of or are based upon any breach of
the representations, warranties or covenants of the Company set forth herein or are based on any
untrue statement or alleged untrue statement of any material fact contained in the Registration
Statement, including the Prospectus, financial statements and schedules, and all other documents
filed as a part thereof, as amended at the time of effectiveness of the Registration Statement,
including any information deemed to be a part thereof as of the time of effectiveness pursuant to
paragraph (b) of Rule 430A, or pursuant to Rules 430B, 430C or 434, of the Rules and Regulations,
or the Prospectus, in the form first filed with the SEC pursuant to Rule 424(b) of the
Rules and Regulations, or filed as part of the Registration Statement at the time of effectiveness if no Rule
424(b) filing is required or any amendment or supplement thereto, or arise out of or are based upon
the omission or alleged omission to state in any of them a material fact required to be stated
therein or necessary to make the statements in the Registration Statement or any amendment or
supplement thereto not misleading or in the Prospectus or any amendment or supplement thereto not
misleading in light of the circumstances under which they were made, or arise out of or are based
in whole or in part on any inaccuracy in the representations or warranties of the Company contained
in this Agreement, or any failure of the

24

 

Company to perform its obligations hereunder or under law, and will promptly reimburse each
Purchaser and each Purchaser/Affiliate for any reasonable legal and other expenses as such expenses
are incurred by such Purchaser or such Purchaser/Affiliate in connection with
investigating, defending or preparing to defend, settling, compromising or paying any such loss,
claim, damage, liability, expense or action; provided, however, that the Company
will not be liable for amounts paid in settlement of any such loss, claim, damage, liability or
action if such settlement is effected without the consent of the Company, which consent shall not
be unreasonably withheld, and the Company will not be liable in any such case to the extent that
any such loss, claim, damage, liability or expense arises out of or is based upon (i) an untrue
statement or alleged untrue statement or omission or alleged omission made in the Registration
Statement, the Prospectus or any amendment or supplement thereto in reliance upon and in conformity
with written information furnished to the Company by or on behalf of the Purchaser expressly for
use therein, (ii) the failure of such Purchaser to comply with the covenants and agreements
contained in Sections 5.9 or 7.3 hereof respecting the sale of the Securities, (iii) the inaccuracy
of any representation or warranty made by such Purchaser herein, or (iv) any statement or omission
in any Prospectus that is corrected in any subsequent Prospectus that was delivered to the
Purchaser prior to the pertinent sale or sales by the Purchaser.

          (b) The
Purchaser will indemnify and hold harmless the Company,
each of its directors, each of its officers who signed the Registration Statement and each person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act, against any losses, claims, damages, liabilities or expenses to which the
Company, each of its directors, each of its officers who signed the Registration Statement or
controlling person may become subject, under the Securities Act, the Exchange Act, or any other
federal or state statutory law or regulation, or at common law or otherwise (including in
settlement of any litigation, but only if such settlement is effected with the consent of
such Purchaser, which consent shall not be unreasonably withheld) insofar as such losses, claims, damages, liabilities or expenses (or actions in
respect thereof as contemplated below) arise out of or are based upon (i) any failure to comply
with the covenants and agreements contained in Sections 5.9 or 7.3 hereof respecting the sale of
the Shares, (ii) the inaccuracy of any representation or warranty made by such Purchaser herein, or
(iii) any untrue or alleged untrue statement of any material fact contained in the Registration
Statement, the Prospectus, or any amendment or supplement thereto, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements in the Registration Statement or any amendment or
supplement thereto not misleading or in the Prospectus or any amendment or supplement thereto not
misleading in the light of the circumstances under which they were made, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue statement or omission
or alleged omission was made in the Registration Statement, the Prospectus, or any amendment or
supplement thereto, in reliance upon and in conformity with written information furnished to the
Company by or on behalf of any Purchaser expressly for use therein; and will reimburse the Company,
each of its directors, each of its officers who signed the Registration Statement or controlling
person for any reasonable legal and other expense incurred by the Company, each of its directors,
each of its officers who signed the Registration Statement or controlling person in connection with
investigating, defending, settling, compromising or paying any such loss, claim, damage, liability,
expense or action; provided, however, that (x) the Purchaser will not be liable for amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent of the Purchaser,
which consent shall not be unreasonably withheld and (y) the Purchaser’s aggregate liability under this Section
7 shall not

25

 

exceed the
amount of proceeds received by the Purchaser on the sale of the Shares pursuant to
the Registration Statement with respect to which the claim for
indemnification here under is being made.

          (c) Promptly after receipt by an indemnified party under this Section 7.4 of notice of the
threat or commencement of any action, such indemnified party will, if a claim in respect thereof is
to be made against an indemnifying party under this Section 7.4 promptly notify the indemnifying
party in writing thereof, but the omission to notify the indemnifying party will not relieve it
from any liability that it may have to any indemnified party for contribution or otherwise under
the indemnity agreement contained in this Section 7.4 to the extent it is not prejudiced as a
result of such failure. In case any such action is brought against any indemnified party and such
indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying
party will be entitled to participate in, and, to the extent that it may wish, jointly with all
other indemnifying parties similarly notified, to assume the defense thereof with counsel
reasonably satisfactory to such indemnified party; provided, however, if the
defendants in any such action include both the indemnified party, and the indemnifying party and
the indemnified party shall have reasonably concluded, based on the
written advise of counsel, which counsel is reasonably
satisfactory to the indemnifying party, that there may be a conflict of interest between the
positions of the indemnifying party and the indemnified party in conducting the defense of any such
action or that there may be legal defenses available to it and/or other indemnified parties that
are different from or additional to those available to the indemnifying party, the indemnified
party or parties shall have the right to select separate counsel to assume such legal defenses and
to otherwise participate in the defense of such action on behalf of such indemnified party or
parties. Upon receipt of notice from the indemnifying party to such indemnified party of its
election to assume the defense of such action and approval by the indemnified party of counsel, the
indemnifying party will not be liable to such indemnified party under this Section 7.4 for any
legal or other expenses subsequently incurred by such indemnified party in connection with the
defense thereof unless (i) the indemnified party shall have employed such counsel in connection
with the assumption of legal defenses in accordance with the proviso to the preceding sentence (it
being understood, however, that the indemnifying party shall not be liable for the expenses of more
than one separate counsel, reasonably satisfactory to such indemnifying party, representing all of
the indemnified parties who are parties to such action) or (ii) the indemnifying party shall not
have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after notice of commencement of action, in each of which cases the
reasonable fees and expenses of counsel shall be at the expense of the indemnifying party. The
indemnifying party shall not be liable for any settlement of any
action without its consent, which consent shall not be unreasonably
withheld. In no event shall any indemnifying party be liable in respect of any amounts paid in
settlement of any action unless the indemnifying party shall have approved in writing the terms of
such settlement; provided that such consent shall not be unreasonably withheld. No
indemnifying party shall, without the prior written consent of the indemnified party, effect any
settlement of any pending or threatened proceeding in respect of
which any indemnified party is a party unless such settlement includes
a complete released of the indemnified
party from all liability on claims that are the subject matter of such proceeding.

     7.5 Termination of Conditions and Obligations. The restrictions imposed by Section
5.10 or Section 7.3 upon the transferability of the Registrable Securities shall cease and
terminate as to any particular number of the Registrable Securities upon the earlier of (i) the
passage of one

26

 

year from the effective date of the Registration Statement covering such Registrable
Securities and (ii) at such time as an opinion of counsel satisfactory in form and substance to the
Company shall have been rendered to the effect that such conditions are not necessary in order to
comply with the Securities Act.

     7.6 Information Available. The Company, upon the reasonable request of the Purchaser,
shall make available for inspection by each Purchaser, any underwriter participating in any
disposition pursuant to the Registration Statement and any attorney, accountant or other agent
retained by the Purchaser or any such underwriter, all financial and other records, pertinent
corporate documents and properties of the Company, and cause the Company’s officers, employees and
independent accountants to supply all information reasonably requested by the Purchaser or any such
underwriter, attorney, accountant or agent in connection with the Registration Statement.

     7.7 Delay in Filing or Effectiveness of Registration Statement. If the Registration
Statement is not filed by the Company with the SEC on or prior to the Filing Deadline, then
for each day following the Filing Deadline, until but excluding the date the Registration Statement
is filed, or if the Registration Statement is not declared effective
by the SEC by the
Effective Deadline, then for each day following the Effective Deadline, until but excluding the
date the SEC declares the Registration Statement effective, the Company shall, for each such
day, pay the Purchaser with respect to any such failure, as liquidated damages and not as a
penalty, an amount per 30-day period equal to 1.0% of the Purchase Price paid by such Purchaser for
its Shares pursuant to this Agreement; and for any such 30-day period, such payment shall be made
no later than three business days following such 30-day period. If the Purchaser shall be
prohibited from selling Conversion Shares under the Registration Statement as a result of a
Suspension of more than sixty (60) days or Suspensions in the aggregate of more than ninety (90)
days each in any 365 day period, then for each day on which a Suspension is in effect that exceeds
the maximum allowed period for a Suspension or Suspensions, but not including any day on which a
Suspension is lifted, the Company shall pay the Purchaser, as liquidated damages and not as a
penalty, an amount per 30-day period equal to 1.0% of the Purchase Price paid by such Purchaser for
its Shares pursuant to this Agreement for each such day, and such payment shall be made no later
than the first business day of the calendar month next succeeding the month in which such day
occurs. For purposes of this Section 7.7, a Suspension shall be deemed lifted on the date that
notice that the Suspension has been lifted is delivered to the Purchaser pursuant to Section 5.9 of
this Agreement. Any payments made pursuant to this Section 7.7 shall not constitute the
Purchaser’s exclusive remedy for such events. Notwithstanding the foregoing provisions, in no
event shall the Company be obligated to pay any liquidated damages pursuant to this Section 7.7 (i)
to more than one Purchaser in respect of the same Shares for the same period of time or (ii) in an
aggregate amount that exceeds 10% of the Purchase Price paid by the Purchasers for the Shares
pursuant to the Agreements. Such payments shall be made to the Purchasers in cash.

     SECTION 8. Anti-Dilution Protection for the Common Stock. If the Company issues
within twelve (12) months of the Closing Date common stock or
securities convertible into common stock at a price per share less than the
Common Stock Purchase Price, then upon the occurrence of such issuance, the Company shall, subject
to Sections 8(a), (b), (c) and (d) below, pay to the Purchaser an amount equal to the difference
between (X) the Common Stock Purchase Price per share minus (Y) the greater of (i)

27

 

the per share cash consideration paid in the transaction giving rise to the adjustment in this
Section 8, and (ii) $2.50, multiplied by (Z) (i) the total number of shares of Common Stock
(assuming the conversion of the Preferred Shares at then applicable Conversion Rate) purchased by
the Purchaser hereunder less (ii) any shares of Company common stock sold by the Purchaser after
the Closing Date.

          (a) In the case of the issuance of Company common stock for a consideration in whole or in
part in cash, the consideration other than cash will be deemed to be the fair value thereof as
determined in good faith by a majority of the Board of Directors irrespective of accounting
treatment.

          (b) No adjustment will be made pursuant to this Section 8:

               (1) if shares of common stock are issued or are issuable pursuant to a stock option plan,
restricted stock plan, agreements or other incentive stock arrangements approved by the
stockholders and a majority of the Board of Directors of the Company; or

               (2) in the event the Company should at any time or from time to time after the Closing Date
fix a record date for the effectuation of a split or subdivision of the outstanding shares of
common stock or the determination of holders of common stock entitled to receive a dividend or
other distribution payable in additional shares of common stock or other securities or rights
convertible into, exchangeable for, or entitling the holder thereof to receive directly or
indirectly, additional shares of common stock (the “Common Stock Equivalents”) without
payment of any consideration by such holder for the additional shares of common stock or the Common
Stock Equivalents (including the additional shares of common stock issuable upon conversion or
exercise thereof).

          (c) In the event a dilutive event under this Section 8 occurs, the Purchaser must provide the
Company with an Officer’s Certificate certifying to how many shares of Company common stock the
Purchaser has sold since the Closing Date.

     SECTION 9. Purchasers That May Receive Non-Public Information. Notwithstanding
anything contained herein to the contrary, the Purchaser may have elected to receive (and therefore
received) certain information that may be deemed to be material non-public information (the
“Confidential Information”). If so, the Purchaser hereby agrees (i) not to use the Confidential
Information for any purpose other than in connection with its evaluation of a possible investment
in the Shares, (ii) to keep all Confidential Information confidential and not to disclose or reveal
in any manner whatsoever any Confidential Information to any person other than such Purchaser’s
representatives who are actively and directly participating in the evaluation of a possible
investment in the Shares or otherwise need to know the Confidential Information for such purpose
and who have been advised by such Purchaser of, and have agreed to be bound by, the restrictions
contained in this Section 8, and (iii) not to affect any transaction in (other than as

28

 

contemplated by this Agreement) any securities of the Company until the earlier of (A) six
months from the date of the Confidentiality Agreement signed by the Purchaser, (B) such time as the
Company in its reasonable opinion determines that the Confidential Information is no longer
considered material non-public information, or (C) or the filing of the Company’s 10Q for the
fiscal quarter ended June 30, 2008.

     SECTION 10. Broker’s Fee. The Purchaser acknowledges that the Company intends to pay
to the Placement Agent a fee in respect of the sale of the Shares to the Purchaser. The Purchaser
and the Company agree that the Purchaser shall not be responsible for such fee and that the Company
will indemnify and hold harmless the Purchaser and each Purchaser/Affiliate against any losses,
claims, damages, liabilities or expenses, joint or several, to which such Purchaser or
Purchaser/Affiliate may become subject with respect to such fee. Each of the parties hereto
represents that, on the basis of any actions and agreements by it, there are no other brokers or
finders entitled to compensation in connection with the sale of the Shares to the Purchaser.

     SECTION 11. Independent Nature of Purchasers’ Obligations and Rights. The obligations
of the Purchaser under this Agreement are several and not joint with the obligations of any Other
Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations
of any Other Purchaser under the Agreements. The decision of each Purchaser to purchase the Shares
pursuant to the Agreements has been made by such Purchaser independently of any other Purchaser.
Nothing contained in the Agreements, and no action taken by any Purchaser pursuant thereto, shall
be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any
other kind of entity, or create a presumption that the Purchasers are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by the Agreements.
Each Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser in
connection with making its investment hereunder and that no Purchaser will be acting as agent of
such Purchaser in connection with monitoring its investment in the Shares or enforcing its rights
under this Agreement. Each Purchaser shall be entitled to independently protect and enforce its
rights, including without limitation the rights arising out of this
Agreement, and it shall not be
necessary for any other Purchaser to be joined as an additional party in any proceeding for such
purpose.

     SECTION 12. Notices. All notices, requests, consents and other communications
hereunder shall be in writing, shall be mailed by first-class registered or certified airmail,
e-mail, confirmed facsimile or nationally recognized overnight express courier postage prepaid, and
shall be deemed given when so mailed and shall be delivered as addressed as follows:

          (a) if to the Company, to:

29

 

Flagstar Bancorp, Inc.

5151 Corporate Drive,

Troy, Michigan 48098-2639

Attention: Mr. Paul Borja

Facsimile: (248) 312-6833

E-mail: paul.borja@flagstar.com

with a copy to:

Kutak Rock LLP

1101 Connecticut Avenue, N.W.

Suite 1000

Washington, DC 20036-4374

Attention: Jeremy Johnson, Esq.

Facsimile: (202) 828-2488

E-mail: jeremy.johnson@KutakRock.com

     or to such other person at such other place as the Company shall designate to the Purchaser in
writing; and

          (b) if to the Purchaser, at its address as set forth at the end of this Agreement, or at such
other address or addresses as may have been furnished to the Company in writing.

     SECTION 13. Changes. This Agreement may not be modified or amended except pursuant to
an instrument in writing signed by the Company and the Purchaser. Any amendment or waiver effected
in accordance with this Section 13 shall be binding upon each holder of any Securities purchased
under this Agreement at the time outstanding, each future holder of all such Securities, and the
Company.

     SECTION 14. Headings. The headings of the various sections of this Agreement have
been inserted for convenience of reference only and shall not be deemed to be part of this
Agreement.

     SECTION 15. Severability. In case any provision contained in this Agreement should be
invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the
remaining provisions contained herein shall not in any way be affected or impaired thereby.

     SECTION 16. Governing Law; Venue. This Agreement is to be construed in accordance
with and governed by the federal law of the United States of America and the internal laws of the
State of New York without giving effect to any choice of law rule that would cause the application
of the laws of any jurisdiction other than the internal laws of the State of New York to the rights
and duties of the parties. Each of the Company and the Purchaser submits to the nonexclusive
jurisdiction of the United States District Court for the Southern District of New York and of any
New York State court sitting in New York City for purposes of all legal proceedings arising out of
or relating to this Agreement and the transactions contemplated hereby. Each of the Company and
the Purchaser irrevocably waives, to the fullest extent permitted by law, any objection that it may
now or hereafter have to the laying of the venue of

30

 

any such proceeding brought in such a court and any claim that any such proceeding brought in
such a court has been brought in an inconvenient forum.

     SECTION 17. Counterparts. This Agreement may be executed in counterparts, each of
which shall constitute an original, but all of which, when taken together, shall constitute but one
instrument, and shall become effective when one or more counterparts have been signed by each party
hereto and delivered to the other parties. Facsimile signatures shall be deemed original
signatures.

     SECTION 18. Entire Agreement. This Agreement and the instruments referenced herein
contain the entire understanding of the parties with respect to the matters covered herein and
therein and, except as specifically set forth herein or therein, neither the Company nor the
Purchaser makes any representation, warranty, covenant or undertaking with respect to such matters.
Each party expressly represents and warrants that it is not relying on any oral or written
representations, warranties, covenants or agreements outside of this Agreement.

     SECTION 19. Fees and Expenses. Except as set forth herein, each of the Company and
the Purchaser shall pay its respective fees and expenses related to the transactions contemplated
by this Agreement.

     SECTION 20. Parties. This Agreement is made solely for the benefit of and is binding
upon the Purchaser and the Company and to the extent provided in Section 7.4, any person
controlling the Company or the Purchaser, the officers and directors of the Company, and their
respective executors, administrators, successors and assigns and subject to the provisions of
Section 7.4, no other person shall acquire or have any right under or by virtue of this Agreement.
The term “successor and assigns” shall include any subsequent purchaser, as such purchaser, of
the Shares sold to the Purchaser pursuant to this Agreement.

     SECTION 21. Further Assurances. Each party agrees to cooperate fully with the other
parties and to execute such further instruments, documents and agreements and to give such further
written assurance as may be reasonably requested by any other party to evidence and reflect the
transactions described herein and contemplated hereby and to carry into effect the intents and
purposes of this Agreement.

[Remainder of Page Left Intentionally Blank]

31

 

     IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly
authorized representatives as of the day and year first above written.

	 	 	 	 	 	 	 	 	 
	 	 	 	 	Flagstar Bancorp, Inc. 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	By:
	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:
	 	 
	 

	 	 	 	 	 	Title:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	Print or Type:	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	Name of Purchaser
	 	 	 	 	(Individual or Institution)
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	Jurisdiction of Purchaser’s Executive Offices
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	Name of Individual representing
	 	 	 	 	Purchaser (if an Institution)
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	Title of Individual representing
	 	 	 	 	Purchaser (if an Institution)
	 

	 	Signature by:	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Individual Purchaser or Individual
	 	 	 	 	 	 	representing Purchaser:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Address:	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Telephone:	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Facsimile:	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	E-mail:	 	 
	 

	 	 	 	 	 	 	 	 

Signature Page to Purchase Agreement

 

 

Schedule I

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Number of	 	 	 	 	 	Number of	 	 	 	 	 	 	 
	Common Stock	 	Price Per	 	 	Preferred Stock	 	 	Price Per	 	 	 	 
	Shares to	 	Share In	 	 	Shares to	 	 	Share In	 	 	Aggregate	 
	Be Purchased	 	Dollars	 	 	Be Purchased	 	 	Dollars	 	 	Price	 
	 
	 	$	 	 	 	 	 	 	 	$	 	 	 	$	 	 

S-1

 

APPENDIX I

(Page 1 of 5)

APPENDIX I

SUMMARY INSTRUCTION SHEET FOR PURCHASER

(to be read in conjunction with the entire

Purchase Agreement which follows)

A. Complete the following items on BOTH Purchase Agreements (Sign two originals):

	 	1.	 	Signature Page:

	 	(i)	 	Name of Purchaser (Individual or Institution)
	 
	 	(ii)	 	Name of Individual representing Purchaser (if an Institution)
	 
	 	(iii)	 	Title of Individual representing Purchaser (if an Institution)
	 
	 	(iv)	 	Signature of Individual Purchaser or Individual representing Purchaser

	 	2.	 	Appendix I — Stock Certificate Questionnaire/Registration Statement
Questionnaire:
	 
	 	 	 	Provide the information requested by the Stock Certificate Questionnaire and the
Registration Statement Questionnaire.
	 
	 	3.	 	Return BOTH properly completed and signed Purchase Agreements including the
properly completed Appendix I to (initially by facsimile with original by
overnight delivery):

Lehman Brothers Inc.

745 Seventh Avenue, 5th Floor

New York, NY 10019

Attention: Keith Canton

Facsimile: 212-520-9328

B. Instructions regarding the transfer of funds for the purchase of Shares will be
sent by facsimile to the Purchaser by the Placement Agent at a later date.

C. Upon the resale of the Securities by the Purchasers after the Registration
Statement covering the Securities is effective, as described in the Purchase
Agreement, the Purchaser:

	 	(i)	 	must deliver a current prospectus of the Company to the buyer
(prospectuses must be obtained from the Company at the Purchaser’s request);
and
	 
	 	(ii)	 	must send a letter in the form of Appendix II to the
Company so that the Securities may be properly transferred.

 

 

APPENDIX I

(Page 2 of 5)

Flagstar Bancorp, Inc.

STOCK CERTIFICATE QUESTIONNAIRE

          Pursuant to Section 3 of the Agreement, please provide us with the following information:

	 	 	 	 	 
	1.

	 	The exact name that your
Securities are to be registered
in (this is the name that will
appear on your stock
certificate(s)). You may use a
nominee name if appropriate:
	 	 
	 	 	 	 	 
	 
	 	 	 	 
	2.

	 	The relationship between the
Purchaser of the Shares and the
Registered Holder listed in
response to item 1 above:
	 	 
	 	 	 	 	 
	 
	 	 	 	 
	3.

	 	The mailing address of the
Registered Holder listed in
response to item 1 above:
	 	 
	 	 	 	 	 
	 
	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 
	4.

	 	The Social Security Number or
Tax Identification Number of
the Registered Holder listed in
response to item 1 above:
	 	 
	 	 	 	 	 

 

 

APPENDIX I

(Page 3 of 5)

Flagstar Bancorp, Inc.

REGISTRATION STATEMENT QUESTIONNAIRE

     In connection with the preparation of the Registration Statement, please provide us with the
following information:

     SECTION 1. Pursuant to the “Selling Stockholder” section of the Registration Statement, please
state your or your organization’s name exactly as it should appear in the Registration Statement:

 

 

     SECTION 2. Please provide the number of shares of Common Stock that you or your organization
own or Preferred Stock that you or your organization own that will convert into Common Stock after
Closing. Please also provide the number of Shares of common stock that you or your organization
purchased through other transactions and provide the number of Shares that you have or your
organization has the right to acquire within 60 days of Closing:

     Shares of Common Stock: ___

     Shares of Common Stock into which Preferred Stock is convertible: ___

     Other shares of common stock held: ___

     Total shares of Common Stock held: ___

     SECTION 3. Have you or your organization had any position, office or other material
relationship within the past three years with the Company or its affiliates?

___Yes ___No

     If yes, please indicate the nature of any such relationships below:

 

 

 

 

 

 

APPENDIX I

(Page 4 of 5)

     SECTION 4. Are you (i) a FINRA Member (see definition), (ii) a Controlling (see definition)
shareholder of a FINRA Member, (iii) a Person Associated with a Member of the FINRA (see
definition), or (iv) an Underwriter or a Related Person (see definition) with respect to the
proposed offering; or (b) do you own any shares or other securities of any FINRA Member not
purchased in the open market; or (c) have you made any outstanding subordinated loans to any FINRA
Member?

     Answer: [   ] Yes [   ] No If “yes,” please describe below

 

 

 

 

 

 

APPENDIX I

(Page 5 of 5)

     Control. The term “control” (including the terms “controlling,” “controlled by” and
“under common control with”) means the possession, direct or indirect, of the power, either
individually or with others, to direct or cause the direction of the management and policies of a
person, whether through the ownership of voting securities, by contract, or otherwise. (Rule 405
under the Securities Act of 1933, as amended)

     FINRA Member. The term “FINRA member” means either any broker or dealer admitted to
membership in the Financial Industry Regulatory Authority, Inc. (“FINRA”). (NASD Manual,
Article I, Definitions)

     Person Associated with a member of the FINRA. The term “person associated with a
member of the FINRA” means every sole proprietor, partner, officer, director, branch manager or
executive representative of any FINRA Member, or any natural person occupying a similar status or
performing similar functions, or any natural person engaged in the investment banking or securities
business who is directly or indirectly controlling or controlled by a FINRA Member, whether or not
such person is registered or exempt from registration with the FINRA pursuant to its bylaws. (NASD
Manual, Article I, Definitions)

     Underwriter or a Related Person. The term “underwriter or a related person” means,
with respect to a proposed offering, underwriters, underwriters’ counsel, financial consultants and
advisors, finders, members of the selling or distribution group, and any and all other persons
associated with or related to any of such persons. (FINRA Interpretation)

 

 

APPENDIX II

[Transfer Agent]

[Address]

Attention:

PURCHASER’S CERTIFICATE OF SUBSEQUENT SALE

	 	 	 
	     The undersigned, [an officer of, or other person duly authorized by]
	 	 
	 

	 	hereby certifies
	 	 	 
	[fill in official name of individual or institution]
	 	 
	that he/she [said institution] is the Purchaser of the shares evidenced by the attached certificate, and as such, sold such shares on

	 	 	 
	 

	 	in accordance with the terms of the Purchase Agreement and in accordance with Registration Statement number
	 	 	 
	[date]
	 	 

	 	 	 
	 

	 	or otherwise in accordance with
	 	 	 
	[fill in the number of or otherwise identify Registration Statement]
	 	 

the Securities Act of 1933, as amended, and, in the case of a transfer pursuant to the Registration
Statement, the requirement of delivering a current prospectus by the Company has been
complied with in connection with such sale.

Print or Type:

	 	 	 	 	 
	Name of Purchaser
(Individual or
Institution):

	 	 
	 	 
	 	 	 	 	 
	 
	 	 	 	 
	Name of Individual
representing
Purchaser (if an
Institution)
	 	 	 	 
	 	 	 	 	 
	 
	 	 	 	 
	Title of Individual
representing
Purchaser (if an
Institution):
	 	 	 	 
	 	 	 	 	 
	Signature by:
	 	 	 	 
	 
	 	 	 	 
	Individual Purchaser 

or Individual repre-

senting Purchaser:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]